Ozempic vs. Saxenda
See how Ozempic and Saxenda compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Ozempic is FDA-approved for type 2 diabetes and to lower cardiovascular and kidney risk; using it for weight loss is off-label, while Saxenda is FDA-approved specifically for chronic weight management.
Ozempic is injected once a week, but Saxenda requires a daily injection with a longer titration schedule.
Saxenda causes gastrointestinal side effects more often, with nausea reported in about 39% of users compared to up to 20% for Ozempic.
Ozempic vs. Saxenda Drug Summary
Ozempic
Ozempic is a GLP-1 receptor agonist FDA-approved to control blood sugar in type 2 diabetes and to lower cardiovascular and kidney risk in adults with heart or kidney disease. It's injected once a week, with the dose slowly raised from 0.25 mg up to 2 mg. Some people use it off-label for weight loss, since it shares its active ingredient with Wegovy.
Saxenda
Saxenda is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults and adolescents 12 and older with obesity or a weight-related condition. It's injected once a day, with the dose raised weekly from 0.6 mg up to a 3 mg maintenance dose. It shares its active ingredient, liraglutide, with Victoza, which is approved for diabetes instead.
Ozempic vs. Saxenda Side Effects
Ozempic
Saxenda
Ozempic vs. Saxenda Dosage
Ozempic
Saxenda
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 2 mg once weekly | If needed |
| Dose changes | 3 increases | Every 4 weeks |
| STAGE | DOSE | WHEN |
| Starting dose | 0.6 mg once daily | Week 1 |
| Maximum dose | 3 mg once daily | Week 5 onward |
| Dose changes | 4 increases | Every week |
Ozempic
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 2 mg once weekly | If needed |
| Dose changes | 3 increases | Every 4 weeks |
Saxenda
| STAGE | DOSE | WHEN |
| Starting dose | 0.6 mg once daily | Week 1 |
| Maximum dose | 3 mg once daily | Week 5 onward |
| Dose changes | 4 increases | Every week |
Ozempic vs. Saxenda Indications
Ozempic
Ozempic is approved to improve blood sugar control in adults with type 2 diabetes, along with diet and exercise. It also carries approvals to reduce cardiovascular risk in diabetics with known heart disease and to slow kidney disease progression in diabetics with chronic kidney disease. It is not approved for weight loss on its own.
Blood sugar control in type 2 diabetes, with diet and exercise
Reduce risk of heart attack, stroke, and death in T2D with heart disease
Slow kidney disease progression in T2D with chronic kidney disease
Not approved for chronic weight management (that's Wegovy)
Saxenda
Saxenda is approved for chronic weight management in adults with obesity, or overweight with a related condition like high blood pressure. It's also approved for adolescents ages 12 to 17 with obesity. It is not approved to treat type 2 diabetes; that use belongs to Victoza, a different liraglutide product.
Chronic weight management in adults with obesity
Chronic weight management in overweight adults with a related condition
Chronic weight management in adolescents 12-17 with obesity
Not approved for type 2 diabetes (see Victoza)
Ozempic vs. Saxenda Pros and Cons
Ozempic
Ozempic's once-weekly dosing and added cardiovascular and kidney benefits make it a strong option for people with type 2 diabetes. Since it isn't FDA-approved for weight loss, insurance coverage for that use is inconsistent and often requires paying out of pocket.
Pros
Only needs to be injected once a week, not daily
FDA-approved to reduce cardiovascular risk in T2D with heart disease
FDA-approved to slow kidney disease progression in T2D with CKD
Longer real-world track record in type 2 diabetes since 2017
Cons
Not FDA-approved for weight loss, so that use is off-label
No pediatric weight-loss approval
Insurance often won't cover it for weight management alone
Saxenda
Saxenda is FDA-approved specifically for chronic weight management, giving it more consistent insurance coverage for that use than off-label options. It requires a daily injection and tends to cause gastrointestinal side effects more often than once-weekly GLP-1 drugs.
Pros
FDA-approved specifically for chronic weight management
Approved for adolescents 12-17 with obesity
More consistent insurance coverage for weight-loss use
Established weight-loss track record since 2014
Cons
Requires a daily injection instead of once a week
Higher rates of nausea, diarrhea, and vomiting than Ozempic
Not approved for type 2 diabetes or cardiovascular/kidney risk reduction
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.